Magin Justin C, Xu Chun, Peskoe Sarah, Dorry Michael, Frankel Courtney W, Dahhan Talal, Snyder Laurie D
Duke University Medical Center, Durham, NC.
Department of Biostatistics and Bioinformatics, Duke University School of Medicine.
Transplant Direct. 2024 Jan 19;10(2):e1572. doi: 10.1097/TXD.0000000000001572. eCollection 2024 Feb.
Pulmonary embolism (PE) is a rare yet serious postoperative complication for lung transplant recipients (LTRs). The association between timing and severity of PE and the development of chronic allograft lung dysfunction (CLAD) has not been described.
A single-center, retrospective cohort analysis of first LTRs included bilateral or single lung transplants and excluded multiorgan transplants and retransplants. PEs were confirmed by computed tomography angiography or ventilation/perfusion (VQ) scans. Infarctions were confirmed on computed tomography angiography by a trained physician. The PE severity was defined by the Pulmonary Embolism Severity Index (PESI) score, a 30-d post-PE mortality risk calculator, and stratified by low I and II (0-85), intermediate III and IV (85-125), and high V (>125). PE and PESI were analyzed in the outcomes of overall survival, graft failure, and chronic lung allograft dysfunction (CLAD).
We identified 57 of 928 patients (6.14%) who had at least 1 PE in the LTR cohort with a median follow-up of 1623 d. In the subset with PE, the median PESI score was 85 (75.8-96.5). Most of the PESI scores (32/56 available) were in the low-risk category. In the CLAD analysis, there were 49 LTRs who had a PE and 16 LTRs (33%) had infarction. When treating PE as time-dependent and adjusting for covariates, PE was significantly associated with death (hazard ratio [HR] 1.8; 95% confidence interval [CI], 1.3-2.5), as well as increased risk of graft failure, defined as retransplant, CLAD, or death (HR 1.8; 95% CI, 1.3-2.5), and CLAD (HR 1.7; 95% CI, 1.2-2.4). Infarction was not associated with CLAD or death. The PESI risk category was not a significant predictor of death or CLAD.
PE is associated with decreased survival and increased hazard of developing CLAD. PESI score was not a reliable predictor of CLAD or death in this lung transplant cohort.
肺栓塞(PE)是肺移植受者(LTR)术后一种罕见但严重的并发症。PE的发生时间和严重程度与慢性移植肺功能障碍(CLAD)的发展之间的关联尚未见报道。
对首次肺移植受者进行单中心回顾性队列分析,包括双侧或单肺移植,排除多器官移植和再次移植。PE通过计算机断层扫描血管造影或通气/灌注(VQ)扫描确诊。梗死由一名经过培训的医生通过计算机断层扫描血管造影确认。PE严重程度由肺栓塞严重程度指数(PESI)评分定义,这是一个计算PE后30天死亡风险的计算器,并分为低风险I和II级(0 - 85)、中风险III和IV级(85 - 125)以及高风险V级(>125)。对PE和PESI在总体生存、移植失败和慢性移植肺功能障碍(CLAD)的结局中进行分析。
在928例患者中,我们确定了57例(6.14%)在LTR队列中至少发生过1次PE,中位随访时间为1623天。在发生PE的亚组中,PESI评分中位数为85(75.8 - 96.5)。大多数PESI评分(32/56例可用)处于低风险类别。在CLAD分析中,有49例LTR发生了PE,其中16例(33%)发生了梗死。将PE视为时间依赖性因素并对协变量进行校正后,PE与死亡显著相关(风险比[HR] 1.8;95%置信区间[CI],1.3 - 2.5),以及移植失败风险增加,移植失败定义为再次移植、CLAD或死亡(HR 1.8;95% CI,1.3 - 2.5),和CLAD(HR 1.7;95% CI,1.2 - 2.4)。梗死与CLAD或死亡无关。PESI风险类别不是死亡或CLAD的显著预测因素。
PE与生存率降低和发生CLAD的风险增加相关。在这个肺移植队列中,PESI评分不是CLAD或死亡的可靠预测指标。